broad-spectrum antibiotic

(redirected from Broad spectrum antibiotic)
Also found in: Dictionary, Encyclopedia.
Related to Broad spectrum antibiotic: ampicillin

antibiotic

 [an″te-, an″ti-bi-ot´ik]
1. destructive of life.
2. a chemical substance produced by a microorganism that has the capacity, in dilute solutions, to kill other microorganisms or inhibit their growth. Antibiotics that are sufficiently nontoxic to the host are used as chemotherapeutic agents in the treatment of infectious diseases. See also antimicrobial agent.
antineoplastic a's (antitumor a's) a class of antineoplastic agents that apparently affect the function or the synthesis, or both, of nucleic acids and thus are cell cycle nonspecific. See also antineoplastic therapy.
broad-spectrum antibiotic one that is effective against a wide range of bacteria, both gram-positive and gram-negative.
β-lactam antibiotic any of a group of antibiotics, including the cephalosporins and the penicillins, whose chemical structure contains a β-lactam ring.

broad-spec·trum an·ti·bi·ot·ic

an antibiotic having a wide range of activity against both gram-positive and gram-negative organisms.

broad-spectrum antibiotic

an antibiotic that is effective against a wide range of infectious microorganisms.

broad-spectrum antibiotic

A therapeutic array used to treat bacterial infections—e.g., acute otitis media.
 
Examples
Azithromycin, clarithromycin, cefixime, cefpodoxime proxetil, cefprozil, ceftriaxone, cefuroxime axetil, loracarbef.
 
Cons
Overuse of broad-spectrum antibiotics facilitates development of antibiotic-resistant infections and multi-drug resistance.

broad-spec·trum an·ti·bi·ot·ic

(brawd-spek'trŭm an'tē-bī-ot'ik)
An antibiotic having a wide range of activity against both gram-positive and gram-negative organisms.

antibiotic

1. destructive of life.
2. a chemical substance produced by a microorganism that has the capacity, in dilute solutions, to kill (biocidal activity) or inhibit the growth (biostatic activity) of other microorganisms. Antibiotics that are sufficiently nontoxic to the host are used as chemotherapeutic agents in the treatment of infectious diseases. See also antimicrobial.
3. used as feed additives to animals as growth promotants.

anthracycline a's
a group of antibiotics which have a tetracycline ring structure substituted with the sugar daunosamine. Includes the antineoplastic drugs doxorubicin and daunorubicin.
antineoplastic antibiotic
bactericidal antibiotic
one that kills bacteria.
bacteriostatic antibiotic
one that suppresses the growth of bacteria.
broad-spectrum antibiotic
one that is effective against a wide range of bacteria.
antibiotic detection
on-farm and prepackaged laboratory tests available for testing farm products and animal tissues and fluids for antibiotic residues.
antibiotic drugs
the range includes the following groups: penicillin, aminoglycoside, tetracycline, chloramphenicol, macrolide, nitrofuran, cephalosporins, and a miscellaneous group including bacitracin, tyrothricin, polymyxin, colistin.
antibiotic feed additives
see feed additives.
first generation antibiotic
one produced as a natural product, e.g. penicillin G. See second generation antibiotic (below).
antibiotic food preservation
is a satisfactory technique but very strictly controlled because of the problem of residues in the food. Used mostly for the preservation of fish.
antibiotic-induced diarrhea
see pseudomembranous colitis, acute undifferentiated diarrhea of the horse.
antibiotic residue in food
in human food of animal origin is a seriously regarded pollution in public health surveillance. The residues may arise from systemic administration, or even after absorption from a local site such as the uterus, but the most serious contamination arises from milk from quarters that have been treated for mastitis. It is essential for the safety of the human population, the financial well-being of the farmer and the professional reputation of the veterinarian that antibacterial withdrawal times are observed.
antibiotic resistance
see antimicrobial resistance.
second generation antibiotic
produced by manipulation of the molecular structure of a first generation antibiotic (see above) so that the metabolism and pharmacodynamics of the original compound are significantly altered.
antibiotic sensitivity test
see antimicrobial sensitivity test.
antibiotic therapy
antibiotics vary in their absorption from the alimentary tract, requiring some, e.g. streptomycin, to be given parenterally for systemic effect, freedom from toxicity, the range of bacteria against which they are effective, their capacity to stimulate resistance and whether they are bacteriostatic or bactericidal in their effects. Selection of the most suitable antibiotic to suit a particular circumstance may be guided by an antimicrobial sensitivity test, knowledge of the infection present and the price of the drug. In many instances, because of lack of knowledge of the infection present it is necessary to choose an agent with a broad antibacterial spectrum.
antibiotic withdrawal, antibiotic withholding
see antibacterial withdrawal time.
References in periodicals archive ?
Antibiotic effectiveness are reduced by the over-use of broad spectrum antibiotics and can also increase the development of drug-resistant germs according to the Centers for Disease Control and Prevention.
Others, known as broad spectrum antibiotics, are effective against a wide range of bacteria.
Patient notes and prescriptions showed that of 21 women aged between 15 and 50 prescribed broad spectrum antibiotics in the department, only nine were asked their drug history and just two given written contraceptive advice.
Unlike the prior example, the increased precision in this diagnosis should actually reduce the variable cost of therapy, because more expensive broad spectrum antibiotics can be replaced by less expensive and more specific antibiotics to complete a patient's treatment once the culture results are known.
Rib-X Pharmaceuticals is developing broad spectrum antibiotics with superior coverage, safety and convenience to deliver new standards of care for patients with serious infections.
a development-stage company with an industry leading pipeline of broad spectrum antibiotics, today announced the promotions of Erin Duffy, Ph.
today announced that the Company has raised $20 million to support ongoing development of the Company's industry-leading broad spectrum antibiotics pipeline, including late-stage clinical development of delafloxacin, which is expected to enter a Phase 2b study in early 2011.
Unlike indiscriminant broad spectrum antibiotics, the specificity of bacteriophage allows targeting of harmful bacteria without compromising the viability of other beneficial microflora or fauna.
A biopharmaceutical company based in Carlsbad, Quorex Pharmaceutical's mission is to discover, develop and commercialize an entirely new class of broad spectrum antibiotics for the effective treatment of serious bacterial infections including those that are resistant to presently available drugs.